BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2158773)

  • 1. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers.
    McMahon BJ; Alberts SR; Wainwright RB; Bulkow L; Lanier AP
    Arch Intern Med; 1990 May; 150(5):1051-4. PubMed ID: 2158773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.
    McMahon BJ; Holck P; Bulkow L; Snowball M
    Ann Intern Med; 2001 Nov; 135(9):759-68. PubMed ID: 11694101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary liver cancer in Alaskan natives. 1980-1985.
    Lanier AP; McMahon BJ; Alberts SR; Popper H; Heyward WL
    Cancer; 1987 Oct; 60(8):1915-20. PubMed ID: 2443234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases.
    Lok AS; Lai CL; Chung HT; Lau JY; Leung EK; Wong LS
    Hepatology; 1991 May; 13(5):834-7. PubMed ID: 1709410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India--an autopsy study.
    Sundaram C; Reddy CR; Ramana GV; Benerjea S; Venkataratnam G; Kumari GS; Reddy BS; Bhaskaran CS
    Indian J Pathol Microbiol; 1990 Oct; 33(4):334-8. PubMed ID: 1966741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaskan Eskimos.
    Popper H; Thung SN; McMahon BJ; Lanier AP; Hawkins I; Alberts SR
    Arch Pathol Lab Med; 1988 May; 112(5):498-504. PubMed ID: 2833872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.
    Villeneuve JP; Desrochers M; Infante-Rivard C; Willems B; Raymond G; Bourcier M; Côté J; Richer G
    Gastroenterology; 1994 Apr; 106(4):1000-5. PubMed ID: 8143967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people.
    Connelly M; Bruce MG; Bulkow L; Snowball M; McMahon BJ
    Liver Int; 2016 Dec; 36(12):1829-1835. PubMed ID: 27224493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathophysiology of persistent hepatitis B virus infection in relation to chronic liver disease and primary hepatocellular carcinoma.
    Shafritz DA; Hadziyannis SJ
    Monogr Pathol; 1987; (28):136-52. PubMed ID: 3023975
    [No Abstract]   [Full Text] [Related]  

  • 10. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus.
    Simonetti J; Bulkow L; McMahon BJ; Homan C; Snowball M; Negus S; Williams J; Livingston SE
    Hepatology; 2010 May; 51(5):1531-7. PubMed ID: 20087968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of hepatocellular carcinoma in Alaska Native families.
    Alberts SR; Lanier AP; McMahon BJ; Harpster A; Bulkow LR; Heyward WL; Murray C
    Genet Epidemiol; 1991; 8(2):127-39. PubMed ID: 1655562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood cancer among Alaska Natives.
    Lanier AP; Holck P; Ehrsam Day G; Key C
    Pediatrics; 2003 Nov; 112(5):e396. PubMed ID: 14595083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus.
    Heyward WL; Lanier AP; McMahon BJ; Fitzgerald MA; Kilkenny S; Paprocki TR
    JAMA; 1985 Dec; 254(21):3052-4. PubMed ID: 2414477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives.
    McMahon BJ; Schoenberg S; Bulkow L; Wainwright RB; Fitzgerald MA; Parkinson AJ; Coker E; Ritter D
    Am J Epidemiol; 1993 Oct; 138(7):544-9. PubMed ID: 8213758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions.
    Lohiya GS; Pirkle H; Nguyen H; Lohiya S; Vuu T
    West J Med; 1988 Apr; 148(4):426-9. PubMed ID: 2838975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus status of black women with hepatocellular carcinoma.
    Kew MC; Rossouw E; Paterson A; Hodkinson J; Whitcutt M; Dusheiko G
    Gastroenterology; 1983 Apr; 84(4):693-6. PubMed ID: 6298050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand.
    Blakely TA; Bates MN; Baker MG; Tobias M
    Int J Epidemiol; 1999 Apr; 28(2):204-10. PubMed ID: 10342680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Matched prospective study on chronic HBsAg carriers and primary hepatocellular cancer].
    Lu JH
    Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):406-8. PubMed ID: 6327215
    [No Abstract]   [Full Text] [Related]  

  • 20. Summaries for patients. Outcomes of chronic infection with hepatitis B virus.
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.